TCGA data demonstrate that ARID1A is among the most frequently mutated genes among different types of cancer, such as stomach adenocarcinomas (18–31%) or uterine corpus endometrioid carcinomas (34%) [46]. This evidence concerns the gene ARID1A and cancer.